TABLE 1.
Full cohort (N = 110) | Matched cohort (N = 46) | |||||
---|---|---|---|---|---|---|
uVATS (N = 72) | Thoracotomy (N = 38) | p‐value | uVATS (N = 23) | Thoracotomy (N = 23) | p‐value | |
Age | 62.5 (56–67) | 67 (60.75–71) | 0.009 | 62.91 (1.69) | 62.95 (1.75) | 0.986 |
Body mass Index | 25.24 (0.44) | 23.25 (0.63) | 0.011 | 24.53 (0.81) | 24.61 (0.81) | 0.949 |
Sex | 0.372 | 1.000 | ||||
Male | 61 (85%) | 35 (92%) | 21 (91%) | 20 (87%) | ||
Female | 11 (15%) | 3 (8%) | 2 (9%) | 3 (13%) | ||
Smoking Index | 20 (0–40) | 52 (0–50) | 0.254 | 40 (0–45) | 20 (0–40) | 0.622 |
Comorbidities | 0.782 | 0.765 | ||||
No | 38 (53%) | 19 (50%) | 14 (61%) | 13 (57%) | ||
Yes | 34 (47%) | 19 (50%) | 9 (39%) | 10 (43%) | ||
ECOG | 0.175 | 1.000 | ||||
0 | 56 (78%) | 25 (66%) | 18 (78%) | 17 (74%) | ||
1 | 16 (22%) | 13 (34%) | 5 (22%) | 6 (26%) | ||
PET‐CT | 0.111 | 0.369 | ||||
No | 42 (58%) | 28 (74%) | 12 (52%) | 15 (65%) | ||
Yes | 30 (42%) | 10 (26%) | 11 (48%) | 8 (35%) | ||
Bronchoscopy | 0.047 | 1.000 | ||||
No | 70 (97%) | 35 (92%) | 22 (96%) | 21 (91%) | ||
Yes | 2 (3%) | 3 (8%) | 1 (4%) | 2 (9%) | ||
Neoadjuvant | 0.202 | 1.000 | ||||
No | 69 (96%) | 38 (100%) | 22 (96%) | 23 (100%) | ||
Yes | 3 (4%) | 0 (0%) | 1 (4%) | 0 (0%) | ||
FEV1% | 92.85 (1.99) | 81.99 (2.71) | 0.002 | 88.15 (3.83) | 90.12 (2.62) | 0.674 |
DLCO% | 88.2 (75.82–98.82) | 82 (68.22–96.90) | 0.148 | 86 (71.2–98.3) | 86.4 (75–99.3) | 0.637 |
Note: Variables are presented as mean ± standard deviation, median (first quartile – third quartile), or n (%). FEV1%, the percent of actual forced expiratory volume in 1 s divided by predicted forced expiratory volume in 1 s. DLCO%, the percent of actual diffusing capacity of the lung for carbon monoxide divided by the predicted diffusing capacity of the lung for carbon monoxide.
Abbreviations: ECOG, Eastern Cooperative Oncology Group; PET‐CT, positron‐emission tomography‐computed tomography; PS, propensity score; uVATS, uniportal video‐assisted thoracic surgery.